Periconceptional folic acid-containing multivitamin supplementation for the prevention of neural tube defects and cardiovascular malformations

Annals of Nutrition and Metabolism

Volumn 59, Issue 1, 2011, Pages 38-40

  Czeizel, Andrew E ^a  

^a FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

Author keywords

Cardiovascular malformations; Folic acid; Folic acid containing multivitamins; Neural tube defects

Indexed keywords

COTRIMOXAZOLE; FOLIC ACID;

ARTICLE; CARDIOVASCULAR MALFORMATION; COMPETITIVE INHIBITION; CONCEPTION; DISEASE SURVEILLANCE; DNA SYNTHESIS; DRUG EFFICACY; DRUG MEGADOSE; EMBRYO DEVELOPMENT; FALLOT TETRALOGY; GENOTYPE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MALPRACTICE; MATERNAL SMOKING; NEURAL TUBE DEFECT; OBESITY; OBSERVATIONAL STUDY; POPULATION RESEARCH; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; VITAMIN SUPPLEMENTATION;

ADULT; CARDIOVASCULAR ABNORMALITIES; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; FEMALE; FOLIC ACID; HUMANS; INFANT, NEWBORN; MALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NEURAL TUBE DEFECTS; PRECONCEPTION CARE; PREGNANCY; PRENATAL CARE;

EID: 82455198805     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000332125     Document Type: Article

References (30)

1. Czeizel AE, Dudás I: Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832-1835. (Pubitemid 23003073)
2. Czeizel AE, Dobó M, Vargha P: Hungarian cohort controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects Res A Clin Mol Teratol 2004; 70: 853-861. (Pubitemid 39602196)
3. Berry RJ, Li Z, Erickson JD, Moore CA, Wang H, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LY, Gindler J, Hong SX, Correa A: Prevention of neural-tube defects with folic acid in China: China-US Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999; 341: 1485-1490.
4. Smithells RW, Sheppard S, Wild J, Schorah CJ: Prevention of neural tube defect recurrences in Yorkshire: final report. Lancet 1989; 2: 498-499. (Pubitemid 19209157)
5. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study - MRC Vitamin Study Research Group. Lancet 1991; 338: 131-137.
6. Czeizel AE: Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996; 62: 179-183.
7. Czeizel AE: Periconceptional folic acid-containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol 1998; 75: 151-161. (Pubitemid 28201105)
8. Botto LD, Khoury MJ, Mulinare J, Erickson JD: Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based case-control study. Pediatrics 1996; 98: 911-917. (Pubitemid 26398775)
9. Botto LD, Mulinare J, Erickson JD: Occurrence of congenital heart defects in relation to maternal multivitamin use. Am J Epidemiol 2000; 151: 878-884. (Pubitemid 30461128)
10. Botto LD, Mulinare J, Erickson JD: Do multivitamin or folic acid supplementation reduce the risk for congenital heart defects? Evidence and gaps. Am J Med Genet 2003; 121A:95-101. (Pubitemid 37075511)
11. Shaw CM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ: Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 1995; 59: 536-545.
12. Czeizel AE, Tóth M, Rockenbaer M: Population-based case control study of folic acid supplementation during pregnancy. Teratology 1996; 53: 345-351. (Pubitemid 26395142)
13. Werler MM, Hayes C, Louik S, Shapiro S, Mitchell AA: Multivitamin supplementation and risk of birth defects. Am J Epidemiol 1999; 150: 675-682. (Pubitemid 29463193)
14. Scanion KS, Ferencz C, Loffredo CA, Wilson PD, Correa-Villasenor A, Khoury MJ, Willett WC: Periconceptional folate intake and malformations of the cardiac outflow tract - Baltimore-Washington Infant Study Group. Epidemiology 1998; 9: 95-98. (Pubitemid 28030498)
15. van Beynum IM, Kapusta L, Bakker MK, den Heijer M, Blom HJ, de Walle HE: Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands. Eur Heart J 2010; 31: 464-471.
16. Ionescu-Ittu R, Marelli AJ, Mackie AS, Pilote L: Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ 2009; 338:b1673.
17. Botto LD, Olney RS, Erickson JD: Vitamin supplement and the risk for congenital anomalies other than neural tube defects. Am J Med Genet 2004; 125C:12-21. (Pubitemid 38140298)
18. Goh YI, Bollano E, Einarson TR, Koren G: Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can 2006; 28: 690-689.
19. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA: Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000; 343: 1608-1614. (Pubitemid 32162984)
20. Czeizel AE, Rockenbaer M, Sorensen HT, Olsen J: The teratogenic risk of trimethoprim- sulfonamides: a population-based case-control study. Reprod Toxicol 2001; 15: 637-646. (Pubitemid 34000933)
21. Czeizel AE, Puho E, Sorensen HT, Olsen J: Possible association between congenital abnormalities and use of different sulfonamides during pregnancy. Congenit Anom 2004; 44: 79-86.
22. van Beynum IM, Kapusta L, den Heijer M, Vermeulen SH, Kouwenberg M, Dani LS, Blom HJ: Maternal MTHFR C 1 T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation. Eur Heart J 2006; 27: 981-987.
23. van Beynum IM, den Heijer M, Kapusta L, Blom HJ: The MTHFR 677C-T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis. QMJ 2007; 100: 743-753.
24. Hobbs CA, Cleves MA, Karim MA: Maternal folate-related gene environment interactions and congenital heart defects. Obstet Gynecol 2010; 116: 316-322.
25. Botto LD, Correa A, Erickson JD: Racial and temporal variation in the prevalence of heart defect. Pediatrics 2001; 107:E32.
26. Mészáros M, Nagy A, Czeizel AE: Incidence of congenital heart disease in Hungary. Hum Hered 1975; 25: 513-519.
27. Boneva RS, Botto LD, Moore CA, Yang O, Correa A, Erickson JD: Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 2001; 103: 2376-2381. (Pubitemid 32448803)
28. Czeizel AE, Révész C: Major malformations of the central nervous system in Hungary. Br J Prev Soc Med 1970; 24: 205-222.
29. Tarusco D (ed): Folic Acid: From Research to Public Health Practice. Rome, Rapporti ISTISAN, 2004.
30. Oakley GP: Inertia on folic acid fortification: Public health malpractice. Teratology 2002; 66: 44-54.